Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial.
Brain
Etienne G C
EG
Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. brain@crh1.org
Mertens
Cécile
C
Girre
Véronique
V
Rousseau
Frédérique
F
Blot
Emmanuel
E
Abadie
Sophie
S
Uwer
Lionel
L
Bourbouloux
Emmanuelle
E
Van Praagh-Doreau
Isabelle
I
Mourey
Loic
L
Kirscher
Sylvie
S
Laguerre
Brigitte
B
Fourme
Emmanuelle
E
Luneau
Sylvia
S
Genève
Jean
J
Debled
Marc
M
D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D002277:Carcinoma / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D015577:Geriatric Assessment / Q000706:statistics & numerical data; D006801:Humans; D026684:Personal Autonomy; D011788:Quality of Life; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D004317:Doxorubicin